The introduction of nicotinamide being a nicotine substitute in e-cigarette and smokeless solutions represents an important regulatory problem for the FDA. Nicotinamide doesn't have nicotinic receptor agonist action and is thought to work as a sedative at substantial dosages6. The promises creat